Catheter Supplier Modifies Medical Devices

A large medical device supplier of catheters wanted to understand the factors driving the use of triple lumen, Peripherally Inserted Central Catheters (PICC) and the vascular access products which would loose sales volume if PICC growth continued. The client needed to understand the market dynamics to modify their business plans for all affected products.

Primary Impact provided information showing dramatic growth for two product segments at the expense of two other product segments.

Intelligence Research determines new product needs

Our team recommended that the company develop two triple lumen PICCs. One for antibiotic therapy and parental nutrition, and one with power injectibility for CT scans.

The analysis showed how the two PICCs were used in therapeutic situations and how the hospital administrators and insurance companies were driving less invasive vascular access. In addition, we presented how the use of certified PICC nurses was dramatically increasing the number of catheter insertions.

We also detailed how the use of Central Venous Catheters (CVCs) and intravenous catheters would change as a result of triple lumen PICC growth.

Impact of R&D

With a clear understanding of the trend in catheter usage, the company modified their business plan to focus on developing a standard and an angiographic triple lumen PICC. Also, they considered product extensions for their existing product lines. Click link to learn more about Primary Impact's medical device industry practice.

Satisfaction Guaranteed
Primary Impact guarantees firsthand answers for your project scope questions.